| Edit |   |
|---|
| Product Name | Recombinant Human Bcl-w (minus C-Terminus) Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 18 kDa, under reducing and non-reducing conditions. MW (theoretical): 19.5 kDa. The Recombinant Human Bcl-w (minus C-Terminus) Protein from R&D Systems is derived from E. coli. The Recombinant Human Bcl-w (minus C-Terminus) Protein has been validated for the following applications: Inhibition Activity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Inhibition Activity |
|---|
| Other Names | Apoptosis regulator Bcl-W, Bcl2-L-2, BCL2L2, BCL2-like 2, Bclw, BCL-W, BCLWbcl-2-like protein 2, KIAA0271BCL2-L-2 |
|---|
| Gene, Accession, CAS # | BCL2L2, Gene ID: 599, Accession: Q92843 |
|---|
| Catalog # | 824-BW-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Bcl-w (minus C-Terminus) Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 23516285 |
|---|